MSB 1.02% 97.0¢ mesoblast limited

Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain, page-170

  1. 371 Posts.
    lightbulb Created with Sketch. 792
    @BarkingGecko good morning, just woken up. Great night last night watching Arsenal. BG you could not be more wrong. Keep your post as a reminder and I’ll make a note to contact you in 3 years and we can compare where we are as a share price compared to 1.50 now. Shorters will be running for cover. OTAT big green tick, our chronic back pain reduction potential has been acknowledged by the FDA ( no conspiracy theories now my shorting friends) and by the way this is just the start. Tide has turned and those holding a short position still have forgotten their trunks, waters have gone cold and we will see their packages shrivel . I am a LTH gave in 5 years minimum. 3 more to go and now these 20x-100 returns are back on. Let the shorters post what they want, no one will be listening. Now for a great Christmas all we need is a fight back in the Ashes. See even I can get carried away.
    regards
    A very happy Yelrom
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.0¢
Change
-0.010(1.02%)
Mkt cap ! $1.107B
Open High Low Value Volume
98.0¢ 98.5¢ 95.5¢ $6.248M 6.438M

Buyers (Bids)

No. Vol. Price($)
1 10000 96.5¢
 

Sellers (Offers)

Price($) Vol. No.
97.0¢ 116040 7
View Market Depth
Last trade - 16.10pm 26/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.